We're working on creating a high-throughput process for the engineering of mammalian cell genomes. We're looking to carry out induced pluripotent stem cell (iPSC) work and advanced robotics to further scale and automate a variety of mammalian workflows for industrial and pharmaceutical applications.
Making biology easier to engineer means we also have to make biology safer to engineer, too. We're helping to develop therapeutics and software that contributes to surveillance infrastructure for viruses including COVID-19 and other respiratory and enteric pathogens.
We’re using yeast to produce cultured ingredients at scale not currently in a company portfolio, or that are sourced from expensive, unpredictable plant-based supply chains.
Ginkgo's enzyme innovation spans diverse applications, from cheesemaking to pharmaceuticals and more. We employ data-driven strategies to achieve enzymatic performance improvements at foundry scale.
Where fermentation is already used in bioindustrial applications, organism engineering can improve the efficiency and sustainability of existing strains. We specialize in optimizing strains to achieve goals like higher titers, better resilience in tough conditions, and the ability to thrive on more affordable inputs.